374 related articles for article (PubMed ID: 15896094)
1. Willingness to pay for a QALY: theoretical and methodological issues.
Gyrd-Hansen D
Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
[TBL] [Abstract][Full Text] [Related]
2. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
3. Diminishing willingness to pay per quality-adjusted life year: valuing acute foodborne illness.
Haninger K; Hammitt JK
Risk Anal; 2011 Sep; 31(9):1363-80. PubMed ID: 21488924
[TBL] [Abstract][Full Text] [Related]
4. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
Olofsson S; Norrlid H; Persson U
J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
[TBL] [Abstract][Full Text] [Related]
5. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
Mavrodi A; Aletras V
Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
[TBL] [Abstract][Full Text] [Related]
6. Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses.
Bala MV; Zarkin GA; Mauskopf JA
Value Health; 2002; 5(4):338-46. PubMed ID: 12102696
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of process utility: elucidating preferences for a non-invasive procedure to treat restenosis.
Aviles-Blanco MV
Health Econ Rev; 2021 Jul; 11(1):27. PubMed ID: 34297212
[TBL] [Abstract][Full Text] [Related]
8. Willingness to pay for QALY: perspectives and contexts in Japan.
Igarashi A; Goto R; Yoneyama-Hirozane M
J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
[No Abstract] [Full Text] [Related]
9. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
Franic DM; Bothe AK; Bramlett RE
J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
[TBL] [Abstract][Full Text] [Related]
10. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
11. Measures of efficiency in healthcare: QALMs about QALYs?
Schlander M
Z Evid Fortbild Qual Gesundhwes; 2010; 104(3):214-26. PubMed ID: 20608250
[TBL] [Abstract][Full Text] [Related]
12. The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature.
Ryen L; Svensson M
Health Econ; 2015 Oct; 24(10):1289-1301. PubMed ID: 25070495
[TBL] [Abstract][Full Text] [Related]
13. Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity.
Mavrodi A; Aletras V; Spanou A; Niakas D
Pharmacoecon Open; 2017 Dec; 1(4):291-300. PubMed ID: 29441505
[TBL] [Abstract][Full Text] [Related]
14. A utility-theoretic model for QALYs and willingness to pay.
Klose T
Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
[TBL] [Abstract][Full Text] [Related]
15. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
Nimdet K; Ngorsuraches S
BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
[TBL] [Abstract][Full Text] [Related]
16. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
17. WTP for a QALY and health states: More money for severer health states?
Shiroiwa T; Igarashi A; Fukuda T; Ikeda S
Cost Eff Resour Alloc; 2013; 11():22. PubMed ID: 24128004
[TBL] [Abstract][Full Text] [Related]
18. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
19. On individual preferences and aggregation in economic evaluation in healthcare.
Liljas B; Lindgren B
Pharmacoeconomics; 2001; 19(4):323-35. PubMed ID: 11383750
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
